LifeCell Launches 'Genome-Scope' Newborn Genetic Testing to Diagnose Over 4000 Genetic Conditions

▴ Lifecell.jpg
~ Provides test results within 10 days to ensure treatment without much delay ~

With over 7000 rare disorders identified so far, it's vastly difficult for doctors to diagnose the same with traditional diagnostic techniques. A recent study showcased that it takes more than 7 physicians & 4 years to diagnose such rare disorders. Misdiagnosis, hidden symptoms & lack of awareness, are the core reasons for the long diagnostic journey of children with genetic disorders.

With >80% of them being genetic in nature, the recent emergence of low-cost genome sequencing it's now possible to detect relevant causative mutations of almost all of these conditions within a single test, thus far exceeding the routine newborn screening tests currently being offered which cover at most 50 conditions.

LifeCell has introduced this test under the brand 'Genome-Scope'. This breakthrough test uses advanced next-gen DNA sequencing technology to assess over 4000 genes related to early childhood-onset disorders, to provide results with >95% accuracy within just 10 days. Thus, it has the potential to not only expedite the diagnostic journey but also, to save lives. While not all conditions detected may have treatment, the parents may seek such information as it may help prepare for the care of the baby and also in future family planning.

Genome-Scope is also available for well-born kids to identify predisposition to genetic conditions that if detected late could cause irreparable harm. It also provides information on how & which medications the child would respond to, thus providing an impetus to the practice of personalised medicine. Genome-Scope will serve as a particularly important tool for those parents with a family history of a genetic disease or those who have previously lost a child to one. However there is also data suggesting that 80% of babies with genetic diseases are born to parents with no family history or symptoms implying the importance of this test to all families.

The test is conducted through a simple process on the cord blood obtained from the baby right after birth for the extraction & preservation of umbilical cord blood stem cells. Alternatively the test could also be done with blood samples obtained from the child after birth through heel prick. The test results are shared with the physician within 10 business days for their reference. Lifecell's in-house certified genetic counsellors would assist the clients in pre and post test counselling. The raw data is also stored with LifeCell for future re-analysis in case there are any changes in the clinical status of the baby.

Mr. Ishaan Khanna, Chief Executive Officer - BioBank & Diagnostics, LifeCell said, "Genome-Scope is yet another milestone in our journey towards providing healthy diagnostic solutions for every stage of the parenthood journey. With Genome-Scope we hope to assist every parent wanting to ensure timely detection of hidden genetic conditions in their newborn that could otherwise go unnoticed. We are also glad that our clients who chose to bank their baby's stem cells with us can now benefit from this service since there is no requirement for a separate sample."

Tags : #lifecell #genomescope #newborngenetictesting

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Transforming Patient Care: HealthTech Startups Making Waves in HealthcareOctober 30, 2024
Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Impressive Growth & Margin Expansion 237% YoY Surge in Net ProfitsOctober 29, 2024
Ramaiah Memorial Hospital Announces the Launch of its Comprehensive State-of-the-art Ramaiah Stroke Center on World Stroke Day October 29, 2024
CarDekho Group's New Auto Segment’s Festive Trend Report: SUVs Lead the Way with a 43% YoY Traffic Increase Across All Sub-SegmentsOctober 29, 2024
World Stroke Day by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.October 29, 2024
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024October 29, 2024
AI Gone Wild? Why OpenAI’s Whisper - Transcription Tool used in Hospitals Might Be Putting Lives at RiskOctober 29, 2024
India’s Humanitarian Aid to Palestine Amid Middle Eastern TurmoilOctober 29, 2024
A Race Against Time How World Stroke Day Highlights India’s Hidden Health CrisisOctober 29, 2024
Hester Biosciences Ltd Consolidated Net Profit in Q2FY25 up 108% Y-o-Y to Rs. 8.39 crore; Revenue up 19% to Rs. 83.69 croreOctober 28, 2024
Is Your Eye Surgery Safe? Inside Chhattisgarh’s Cataract Infection ScandalOctober 28, 2024
Can PM Modi’s 13,000 Crore Investment Reframe India’s Approach to Health?October 28, 2024
Herbalife India and IIT Madras Launch 1,000 Data Science Scholarships, Expanding Quality Education Access for Underserved CommunitiesOctober 28, 2024
American Oncology Institute (AOI) in Imphal Successfully Treats Advanced Thyroid Cancer CasesOctober 28, 2024
Beyond the Flare: Revolutionizing Psoriasis Care for a Brighter Tomorrow!October 28, 2024
Toxic Threat in Chennai’s Tiruvottiyur School: Inside the Mystery Gas Leak That Left Students HospitalizedOctober 26, 2024
Are You Scrolling Your Life Away? The Dark Reality of Digital AddictionOctober 26, 2024
Are You Scrolling Your Life Away? The Dark Reality of Digital AddictionOctober 26, 2024